TrialPloS one2014

MABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicide.

Georgina C Morris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.